However, a hierarchical order of secondary efficacy endpoints is detailed in Supplementary Table S1 , in which statistical significance was no longer reported after the first endpoint failed to reach statistical significance ( p > 0.05). 3.
← all excerpts
The effect of a topical curcumin formulation (VAS-101) on knee pain in adults with knee osteoarthritis: a randomised, double-blind, placebo-controlled study.
2
0.0500
0.0860
The sentences
Moreover, 32.1% of participants in the VAS-101 group achieved an MCID, compared to 13.3% in the placebo group; however, this difference did not reach statistical significance ( p = 0.086).